SCHEMBL18100424

SCHEMBL18100424

COC(=Nc1ccccc1)c1cc(/C(=N/c2ccccc2)OC)cc(/C(=N\c2ccccc2)OC)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 5/20 0.45
▸ NOS3 P29474 3/20 0.45
▸ MAPT P10636 2/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ HTR3E A5X5Y0 2/20 0.41
▸ HTR3B O95264 2/20 0.41
▸ HTR3A P46098 2/20 0.41
▸ HTR3D Q70Z44 2/20 0.41
▸ HTR3C Q8WXA8 2/20 0.41
▸ SLC22A2 O15244 1/20 0.41
▸ SLC22A1 O15245 1/20 0.41
▸ SLC22A3 O75751 1/20 0.41
▸ PLAU P00749 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18100314 1.00 NOS1 (0.45) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL5178578 0.89 KMT2A (0.48) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL18100295 0.89 MAPT (0.48) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL18100417 0.89 KMT2A (0.48) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL18100418 0.85 TSHR (0.45) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL18100306 0.85 CASP3 (0.42) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL18100300 0.84 MAPT (0.44) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL18100310 0.84 NOS1 (0.45) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL18100359 0.83 TSHR (0.43) NOS1NOS3MAPTCASP3RAB9A
SCHEMBL15191710 0.82 MAPT (0.56) NOS1NOS3MAPTCASP3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2016-09-29 — — US disclosed
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2016-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE BRS3, RAD1, RAD51 NOS1 3561/4885NOS3 2933/4885MAPT 3599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback